BRIEF-AstraZeneca Plans $2 Bln Manufacturing Investment In Maryland

+1.15%

-0.17%

-0.18%

-0.42%

Astrazeneca PLC Sponsored ADR AZN	90.85	+1.15%
Dow Jones Industrial Average DJI	47478.10	-0.17%
S&P 500 index SPX	6828.22	-0.18%
NASDAQ IXIC	23478.46	-0.42%

Nov 21 (Reuters) - AstraZeneca PLC AZN.L:

ASTRAZENECA PLANS $2 BILLION MANUFACTURING INVESTMENT IN MARYLAND
ASTRAZENECA: NEW CAPACITY AT FREDRICK AND GAITHERSBURG FACILITIES TO ACCELERATE PRODUCTION OF CANCER, RARE & CHRONIC DISEASE MEDICINES
ASTRAZENECA: INVESTMENT TO SUPPORT 2,600 JOBS ACROSS TWO SITES IN STATE AND CREATION OF 300 SKILLED JOBS
ASTRAZENECA: FREDERICK FACILITY EXPECTED TO BE OPERATIONAL IN 2029; GAITHERSBURG FACILITY TO BE FULLY OPERATIONAL BY 2029

Further company coverage: AZN.L

((Reuters.Briefs@thomsonreuters.com;))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.